Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers, Aged”

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06556147
What this trial is testing

RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults

Who this might be right for
Healthy Volunteers
Sanofi 144
Not applicableStudy completedNCT02142855
What this trial is testing

Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training

Who this might be right for
Healthy
University of Nottingham 60
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Early research (Phase 1)Study completedNCT06944717
What this trial is testing

A Trial of a Norovirus G1.1 and G2.4 Vaccine Administered Orally to Healthy Participants Aged ≥ 18 Years and ≤ 80 Years Old

Who this might be right for
Norovirus Infections
Vaxart 60
Very early researchUnknownNCT05805618
What this trial is testing

Evaluation of Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects

Who this might be right for
Gastroenteritis
Syneos Health 60
Large-scale testing (Phase 3)Study completedNCT03932682
What this trial is testing

Efficacy Study With QIVc in Pediatric Subjects

Who this might be right for
Influenza, Human
Seqirus 5,723
Early research (Phase 1)Study completedNCT02415790
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 112
Early research (Phase 1)Study completedNCT02070289
What this trial is testing

Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)

Who this might be right for
Healthy
Pfizer 50
Post-approval studies (Phase 4)Looking for participantsNCT07730450
What this trial is testing

Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age

Who this might be right for
COVID-19 Vaccines
BioNTech SE 200
Early research (Phase 1)Study completedNCT01028521
What this trial is testing

First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100

Who this might be right for
Healthy
CellMed AG, a subsidiary of BTG plc. 56
Early research (Phase 1)Study completedNCT04171752
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers

Who this might be right for
GeriatricsHealthy
Genfit 21
Not applicableLooking for participantsNCT07442097
What this trial is testing

Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults

Who this might be right for
Aging, Healthy
YOXLO B.V. 16
Early research (Phase 1)Study completedNCT02796118
What this trial is testing

Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects

Who this might be right for
Healthy Subjects
Astellas Pharma Inc 36
Early research (Phase 1)Study completedNCT00093561
What this trial is testing

Lycopene in Preventing Prostate Cancer in Healthy Participants

Who this might be right for
Prostate Cancer
University of Illinois at Chicago
Testing effectiveness (Phase 2)Study completedNCT01419925
What this trial is testing

Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly Volunteers

Who this might be right for
InfluenzaHealthy
BiondVax Pharmaceuticals ltd. 120
Not applicableStudy completedNCT05572450
What this trial is testing

Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain

Who this might be right for
Influenza A H1N1
Hvivo 70
Early research (Phase 1)Study completedNCT00214461
What this trial is testing

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

Who this might be right for
Clostridium Infections
Sanofi 48
Large-scale testing (Phase 3)Study completedNCT01274897
What this trial is testing

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 450
Early research (Phase 1)Study completedNCT02461160
What this trial is testing

Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study

Who this might be right for
Healthy Volunteers
Takeda 88
Large-scale testing (Phase 3)Ended earlyNCT02992418
What this trial is testing

Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects

Who this might be right for
Dengue FeverDengue Hemorrhagic Fever
Sanofi Pasteur, a Sanofi Company 688
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation